Large Inflow of Money Detected in Cardinal Health

Cardinal Health (CAH) : Mondays money flow data in Cardinal Health (CAH) suggests that the bulls made the most of the weakness in the stock. The inflow of money into the stock on upticks was $18.23 million, whereas, $16.42 million worth of transactions were done on downticks. The ratio between the two, uptick and downtick stood at 1.11, in favor of the bulls. The total money flow into the stock was $1.81 million clearly indicating that the smart money has been buying into the stock on weakness.

In comparison, the money flow in block deals was $2.89 million. The total value of block trades done on upticks was $2.89 million. Cardinal Health (CAH) fell $0.37 and traded at $83.24, down -0.44% for the day, over previous days close. On a weekly basis, the shares are -1.33% over the previous weeks close.


Cardinal Health, Inc. has dropped 0.7% in the last five trading days, however, the shares have posted positive gains of 1.01% in the last 4 weeks. Cardinal Health, Inc. is up 8.14% in the last 3-month period. Year-to-Date the stock performance stands at -5.81%.

Cardinal Health (NYSE:CAH): The stock opened at $83.25 on Monday but the bulls could not build on the opening and the stock topped out at $83.49 for the day. The stock traded down to $83.05 during the day, due to lack of any buying support eventually closed down at $83.19 with a loss of -0.49% for the day. The stock had closed at $83.60 on the previous day. The total traded volume was 1,392,896 shares.

In a related news, The Securities and Exchange Commission has divulged that Barrett George S, director officer (Chairman and CEO) of Cardinal Health Inc, had unloaded 250,000 shares at an average price of $83.65 in a transaction dated on August 8, 2016. The total value of the transaction was worth $20,912,500.

Cardinal Health, Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States, the Companys Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers, hospitals and other healthcare providers. In China, the Pharmaceutical segment distributes branded, generic and specialty pharmaceutical, over-the-counter healthcare and consumer products, provides logistics, marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical, surgical and laboratory products and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.